Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories

The latest announcement is out from Kalray SA ( ($FR:ALKAL) ). Kalray reported strong first‑half 2026 results that underline its shift to a higher‑...

Kalray turns profitable in H1 2026 and secures strategic AI chip licences

Abits Group ( ($ABTS) ) has shared an update. On September 14, 2026, Abits Group Inc entered into a Securities Purchase Agreement with an instituti...

Abits Group Secures Note Financing and $250 Million Equity Line to Bolster Capital Structure

The Schwab U.S. Dividend Equity ETF (SCHD) and the Vanguard Dividend Appreciation ETF (VIG) are two popular dividend ETFs, but they are built for d...

SCHD vs. VIG: Which Dividend ETF Has the Edge in 2026?

Insiders have been trading these 5 stocks: (($ABT)), (($VST)), (($U)), (($UAL)) and (($NU)). Here is a breakdown of their recent trades and their v...

Abbott, Vistra, Unity, United, Nu: Insider Shockwave

Shares in medical technology group Boston Scientific ($BSX) dipped over 3% in pre-market trading after it revealed it had been hit by a major cyber...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ABT	$102.01	-1.43%	1.65M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ABT	$102.01	-1.4%	1.65M
3
4
5
6

ABT

Get Abbott Laboratories Data in Excel

Get Abbott Laboratories Data in Excel